淋巴瘤PCR芯片可用于研究与淋巴瘤发展，疾病分型，预后以及治疗反应中关键的84个基因的表达。该芯片包含有和淋巴瘤相关的信号通路包括细胞黏附，细胞周期，免疫以及炎症反应，PI3K/AKT，T细胞分化的关键基因；芯片上还包含有这些通路中淋巴瘤治疗靶标，淋巴瘤样品中常规检测的基因以及启动子发生甲基化变化的基因。利用实时定量PCR，研究者可以方便并且可信地对与淋巴瘤发生发展以及转移相关的基因进行同时检测。
Differentially Methylated Promoters: AFF1, ATM, CADM1 (TSLC1), CCND1, CDH1 (E-Cadherin), CDH13, CDKN1C (p57KIP2), CDKN2B (p15INK4B), CDKN2C (p18INK4C), DAPK1, DLC1, FHIT, GSTP1, HIC1, HRK, ID4, LRP1B, MLH1, MYOD1, RASSF1, RBP1, SLC19A1, TIMP2, TIMP3. DLBCL Survival: ASB13, BCL6, ITPKB, LMO2, LRMP, MYBL1, PAG1, PTK2, TTC9, VGLL4. Follicular Lymphoma Survival: C1QA, CCR1, F8, FCGR1A, FLT3LG, STAT4, TLR5, TNFRSF1B, TNFSF13B. Lymphoma Therapeutic Targets: BCL6, BIRC5, BTK, CD22, CD40 (TNFRSF5), CD80, CXCR4, FCGR1A, HSP90AA1, MCL1, MS4A1, MTOR, NOTCH1, PARP1 (ADPRT1), PTK2, SRC, SYK, TGFB1, TNFSF13B. Inflammatory Response: C1QA, CCR1, CD40 (TNFRSF5), CD40LG (TNFSF5), CSF3 (GCSF), CXCR4, F8, IL6, NFKB1, TGFB1, TLR5, TNF, TNFRSF1B. Immune System Process: BCL6, C1QA, CADM1 (TSLC1), CD2, CD4, CD40 (TNFRSF5), CD5, CD79A, CD80, FCER2, IFNG, IL2, IL6, ITPKB, PDLIM7, PTPRC, SYK, TGFB1, TNFSF13B. T Cell Differentiation: BCL2, CD3D, CD4, CD8A, ITPKB, IL2, PTPRC, SYK, TGFB1, TP53. Cell Adhesion: BCL2, CADM1 (TSLC1), CCR1, CD2, CD22, CD34, CD4, CD40LG (TNFSF5), CD47, CD8A, CDH1 (E-Cadherin), CDH13, DLC1, F8, IL2, NCAM1, PTPRC, SRC, SYK, TNF. Cell Cycle: ATM, BCL2, BIRC5, CCND1, CDKN1C (p57KIP2), CDKN2B (p15INK4B), CDKN2C (p18INK4C), ID4, IFNG, MKI67, MLH1, MYC, RASSF1, TGFB1, TP53. PI3K/AKT Signaling: ALK, BCL2, BTK, CCND1, CCR1, CD2, CD4, CD40 (TNFRSF5), CD40LG (TNFSF5), CSF3 (GCSF), CXCR4, HSP90AA1, IL2, IL6, MTOR, PTK2, SYK, TGFB1, TIMP2, TIMP3, TNFRSF1B, TNFSF13B, TP53. Gene Fusion: ALK, MME. DNA Repair: DNTT

淋巴瘤PCR芯片Lymphoma PCR Array信息由上海英拜生物科技有限公司为您提供，如您想了解更多关于淋巴瘤PCR芯片Lymphoma PCR Array报价、型号、参数等信息，欢迎来电或留言咨询。

注：该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案，不可用于临床诊断或治疗等相关用途